EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Dexmedetomidine vs. propofol on arrhythmia in cardiac surgery: a meta-analysis of randomized controlled trials

Juan Peng, Yifan Wu, Lin Li, Panpan Xia, Peng Yu, Jing Zhang, Xiao Liu

Frontiers in Cardiovascular Medicine · 10.10.2024 · 11

DOI: 10.3389/fcvm.2024.1433841 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 10.10.2024. Verfasst von Juan Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Third Hospital of Nanchang, Nanchang, Jiangxi, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dexmedetomidine (DEX) and propofol are popular anesthetics, but it remains unknown whether DEX reduces the incidence of arrhythmias compared with propofol after cardiac surgery.

Methods

We performed a comprehensive search for RCTs (Randomized Controlled Trials) that compared the incidence of arrhythmias between DEX and propofol in adults who had undergone cardiac surgery across three databases (PubMed, Embase, the Cochrane Library), and ClinicalTrials.gov up to October 3, 2023. The primary outcome was ventricular arrhythmias, the secondary outcomes were bradycardia and atrial fibrillation (AF).

Results

Our analysis included 7 RCTs with 1,004 patients (mean age: 64.37, male: 71.11%) undergoing cardiac surgery, and the incidence of in-hospital arrhythmia was 22.01% (ventricular arrhythmias 2.75%, bradycardia 3.33%, AF 18.63%). Perioperative or postoperative use of DEX reduced the incidence of in-hospital ventricular arrhythmias [Odds Ratio (OR) 0.14, 95% Confidence Interval (CI) 0.03–0.66], but increased the risk of in-hospital bradycardia (OR 2.88, 95% CI 1.02–8.17) compared with propofol. The trial sequence analysis verified the adequacy of sample size and robustness of the ventricular arrhythmias and bradycardia. There was no significant reduced incidence of the use of DEX in the incidence of AF (OR 0.69, 95% CI 0.36–1.29). The GRADE assessment indicated a high certainty for ventricular arrhythmias and bradycardia and a moderate certainty for AF.

Conclusions

Our findings suggested the use of DEX reduces in-hospital ventricular arrhythmias but increases bradycardia incidence compared to propofol in adult patients undergoing cardiac surgery. Further studies are needed to assess the impact of dexmedetomidine on atrial fibrillation compared to propofol. Systematic Review Registration http://www.crd.york.ac.uk/prospero/ PROSPERO, identifier (CRD42023482193).

Schlagwörter

Stichwörter der Autor:innen

cardiac surgerydexmedetomidinemeta-analysispropofolventricular arrhythmias

Autor:innen und Institutionen

  • Department of Anesthesiology, The Third Hospital of Nanchang, Nanchang, Jiangxi, China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Arrhythmia and Electrophysiology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun…

Zitieren

APA

Peng, J., Wu, Y., Li, L., Xia, P., Yu, P., Zhang, J., & Liu, X. (2024). Dexmedetomidine vs. propofol on arrhythmia in cardiac surgery: a meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1433841

Vancouver

Peng J, Wu Y, Li L, Xia P, Yu P, Zhang J, et al. Dexmedetomidine vs. propofol on arrhythmia in cardiac surgery: a meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1433841

BibTeX
@article{Peng2024,
  author = {Peng, Juan and Wu, Yifan and Li, Lin and Xia, Panpan and Yu, Peng and Zhang, Jing and Liu, Xiao},
  title = {Dexmedetomidine vs. propofol on arrhythmia in cardiac surgery: a meta-analysis of randomized controlled trials},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1433841}
}
Kostenlos starten →